MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Operating Expenses of $48.9 million for Q4 2025, up 5.23% on a QoQ basis from $46.5 million in Q3 2025, and down 7.54% year-over-year from $52.9 million in Q4 2024.
MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Operating Expenses history runs 9 years deep, the most recent figure standing at $48.9 million for Q4 2025.
- Quarterly Operating Expenses fell 7.54% year-over-year to $48.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $187.4 million (down 5.13% YoY) and the FY2025 annual result came in at $187.4 million, down 5.13% from the prior year.
- Operating Expenses was $48.9 million for Q4 2025 at MeiraGTx Holdings, up from $46.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $52.9 million in Q4 2024 and bottomed at $25.6 million in Q2 2021.
- A 5-year average of $38.9 million and a median of $36.8 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2021 — Operating Expenses soared 118.16% — and 2025, when it fell 8.81%.
- MeiraGTx Holdings' Operating Expenses stood at $28.7 million in 2021, then advanced by 24.48% to $35.8 million in 2022, then advanced by 28.03% to $45.8 million in 2023, then gained by 15.47% to $52.9 million in 2024, then decreased by 7.54% to $48.9 million in 2025.
- Business Quant data shows MGTX's Operating Expenses at $48.9 million in Q4 2025, $46.5 million in Q3 2025, and $48.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 48.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.89 Mn |
| Sep 30, 2025 | 46.46 Mn |
| Jun 30, 2025 | 48.48 Mn |
| Mar 31, 2025 | 43.52 Mn |
| Dec 31, 2024 | 52.88 Mn |
| Sep 30, 2024 | 50.95 Mn |
| Jun 30, 2024 | 46.19 Mn |
| Mar 31, 2024 | 47.47 Mn |
| Dec 31, 2023 | 45.79 Mn |
| Sep 30, 2023 | 37.87 Mn |
| Jun 30, 2023 | 32.33 Mn |
| Mar 31, 2023 | 35.09 Mn |
| Dec 31, 2022 | 35.77 Mn |
| Sep 30, 2022 | 27.62 Mn |
| Jun 30, 2022 | 34.52 Mn |
| Mar 31, 2022 | 34.37 Mn |
| Dec 31, 2021 | 28.73 Mn |
| Sep 30, 2021 | 29.50 Mn |
| Jun 30, 2021 | 25.60 Mn |
| Mar 31, 2021 | 26.63 Mn |